RB-07-16

N/A

Report date: 2023/11/24 16:28:36
NME

Base Information

Drug NameRB-07-16
Drug Alias NameRB-07-16
ClassificationSmall molecules
Mechanisms of ActionGeranylgeranyl pyrophosphate synthase inhibitors
TargetsGeranylgeranyl pyrophosphate synthase
Therapy Area/IndicationsMultiple MyelomaCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMcGill University
China Registration ClassN/A

Develop Information

Active CompaniesMcGill University
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A